Literature DB >> 10981085

Left ventricular hypertrophy: unresolved issues.

J A Schoenberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10981085     DOI： 10.1007/s11906-999-0041-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  17 in total

1.  Congestive heart failure in the community: trends in incidence and survival in a 10-year period.

Authors:  M Senni; C M Tribouilloy; R J Rodeheffer; S J Jacobsen; J M Evans; K R Bailey; M M Redfield
Journal:  Arch Intern Med       Date:  1999-01-11

2.  Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol.

Authors:  B Trimarco; N De Luca; G Rosiello; B Ricciardelli; S Betocchi; P P Filardi; M Raponi; M Condorelli
Journal:  Am J Cardiol       Date:  1989-10-01       Impact factor: 2.778

3.  Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study.

Authors:  D Levy; K M Anderson; D D Savage; W B Kannel; J C Christiansen; W P Castelli
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

4.  Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.

Authors:  R E Schmieder; P Martus; A Klingbeil
Journal:  JAMA       Date:  1996-05-15       Impact factor: 56.272

5.  Regression of cardiovascular structural changes by antihypertensive treatment. Functional consequences and time course of reversal as judged from clinical studies.

Authors:  B Trimarco; J Wikstrand
Journal:  Hypertension       Date:  1984 Nov-Dec       Impact factor: 10.190

Review 6.  Clinical trials of single-drug therapy for the cardiac effects of hypertension.

Authors:  J S Gottdiener
Journal:  Am J Hypertens       Date:  1999-01       Impact factor: 2.689

Review 7.  Clinical studies of drug reversal of hypertensive left ventricular hypertrophy.

Authors:  P R Liebson
Journal:  Am J Hypertens       Date:  1990-06       Impact factor: 2.689

8.  Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment.

Authors:  M L Muiesan; M Salvetti; D Rizzoni; M Castellano; F Donato; E Agabiti-Rosei
Journal:  J Hypertens       Date:  1995-10       Impact factor: 4.844

9.  Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  J S Gottdiener; D J Reda; B J Materson; B M Massie; A Notargiacomo; R J Hamburger; D W Williams; W G Henderson
Journal:  J Am Coll Cardiol       Date:  1994-11-15       Impact factor: 24.094

10.  Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman; B M Massie; E D Freis; M S Kochar; R J Hamburger; C Fye; R Lakshman; J Gottdiener
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.